Micot
0
Micot reports Phase II endpoint met for MT200605
0

The company said the high-dose group showed a statistically significant improvement in 90-day functional outcomes, but detailed efficacy ...

Som2ny Network
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart